DSI Research, LLC- Springboro

04/23/2026

Cirrhosis Isn’t Always About Alcohol
Many people are surprised to learn that cirrhosis can develop without alcohol use.
Conditions like nonalcoholic fatty liver disease (NAFLD/NASH), hepatitis B or C, autoimmune liver disease, and genetic conditions can all lead to cirrhosis.
✅ Raising awareness helps reduce stigma
✅ Early diagnosis can slow progression
✅ Liver health matters for everyone
If you or someone you love has liver disease, you’re not alone. 💙 For information about the clinical trials we conduct in this space, please call (937) 469-8047

04/20/2026

Are you struggling with weight and dealing with conditions like diabetes or high blood pressure? You’re not alone, and it might be time to take a closer look at your liver health.
Being overweight combined with conditions like:
✔️ Type 2 Diabetes
✔️ High Blood Pressure
✔️ High Cholesterol
✔️ High Triglycerides
These risk factors may increase your risk of Fatty Liver Disease (MASH).
The good news? You may qualify for clinical research studies that are exploring new ways to treat and manage this condition.
💡 Take the next step toward better health today.
📞 Call 855-460-8031 or click here to see if you qualify https://objective.health/contact/
Your health matters, don’t wait.

03/06/2026

🌟 Have you been struggling to improve your liver health?

You may be eligible to participate in the SYNCHRONY Histology clinical research study, which is exploring a potential investigational treatment for people living with NASH/MASH (a type of fatty liver disease).

🔬 This study is researching whether a once-weekly investigational medication may help slow or reverse liver scarring in adults diagnosed with or suspected of having NASH/MASH. Participants will receive study-related care from experienced medical professionals, and study visits, tests, and medications are provided at no cost.

✔️ You may qualify if you:
• Are between 18–80 years old
• Have been diagnosed with NASH/MASH or may have signs of it
• Have type 2 diabetes or other metabolic conditions

Participation is voluntary, and reimbursement for reasonable travel expenses may be available.

👉 Learn more and see if you may qualify today:
https://akerosynchronyprogram.com/

The SYNCHRONY Histology study is seeking participants for a clinical study for adults who are living with non-cirrhotic nonalcoholic steatohepatitis, or NASH.

02/28/2026

If you are 18-80 years old, and have nonalcoholic steatohepatitis, you may be eligible for the ENLIGHTEN Fibrosis study that is currently enrolling. Learn about the clinical trial by contacting //DSI Research - Springboro at 937-469-8047// or DSI Research - Northridge at 937-469-8713 or visiting enlightenstudy.com/131social

01/20/2026

12/13/2025

Actively screening! Contact us to see if you’re eligible
937-469-8047

12/13/2025

Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage clinical trial, the company announced. Read more below.

12/02/2025

📣Exciting Opportunity! 📣
Objective Health is officially hiring for a part-time Nurse Practitioner or Physician Assistant, and we are thrilled to spread the word!
If you or someone you know is looking for a role that blends patient care with innovative research, check out the link below!

Sub Investigator - Part-TimeObjectiveHealth is seeking a licensed Nurse Practitioner (NP) or Physician Assistant-Certified (PA-C) to serve as a Part-Time Sub-Investigator at our Dayton, OH research site. This is a unique opportunity for an advanced practice provider in Internal Medicine, Family Medi...

09/11/2025

Excited that we got to be part of this and work on this trial!